Mashup Score: 1
STATA FDA advisory panel concluded that a Biogen treatment for a rare, genetic form of ALS should be conditionally approved, despite unanswered
Mashup Score: 1
STATA FDA advisory panel concluded that a Biogen treatment for a rare, genetic form of ALS should be conditionally approved, despite unanswered
Pharmalot.. Pharmalittle.. Good Morning: FDA panel backs conditional approval for Biogen ALS drug; Pharma fights employer tactic for lowering specialty med costs & More news.. https://t.co/5FEQNvEL5h #pharma #COVID19 #vaccines #ALS #Alzheimers $ABBV $MRNA $BIIB $SNY $REGN $CDTX - view on twitter